Answers are grounded in this paper and cite their sources.
This meta-analysis of individual patient data from 6 clinical trials confirms the efficacy of existing therapies in patients with progressive multiple sclerosis showing disease activity and assesses the role of lesion reduction as a mediator of treatment effect.
No takes yet. Share an insight, caveat, or question.
Montobbio et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: